Harmol hydrochloride

Harmol hydrochloride 是一种具有口服活性的 β-carboline 生物碱,作为 TFEB 激活剂和单胺氧化酶抑制剂,可诱导细胞有丝分裂、自噬 (Autophagy) 和凋亡 (Apoptosis),并通过调节自噬-溶酶体通路促进 α-突触核蛋白 (α-synuclein) 降解,具有抗肿瘤、抗抑郁和延缓衰老的活性,并能改善小鼠帕金森模型的运动损伤。
产品编号: MS-Z61483 CAS No.: 40580-83-4 分子式: C12H11ClN2O 分子量: 234.68
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Harmol hydrochloride 是一种具有口服活性的 β-carboline 生物碱,作为 TFEB 激活剂和单胺氧化酶抑制剂,可诱导细胞有丝分裂、自噬 (Autophagy) 和凋亡 (Apoptosis),并通过调节自噬-溶酶体通路促进 α-突触核蛋白 (α-synuclein) 降解,具有抗肿瘤、抗抑郁和延缓衰老的活性,并能改善小鼠帕金森模型的运动损伤。

生物实验数据

生物活性 Harmol hydrochloride is an orally active β-carboline alkaloid that acts as a TFEB activator and monoamine oxidase inhibitor, induces cell mitosis, autophagy, and apoptosis, promotes α-synuclein degradation by regulating the autophagy-lysosomal pathway, exhibits anti-tumor, anti-depressant, and anti-aging activities, and ameliorates motor impairment in mouse models of Parkinson's disease.
体外研究
(In Vitro)

Harmol (3-30 μM,6-24 h) hydrochloride 在 PC12 细胞中,以剂量和时间依赖的方式降低 α-syn。
Harmol (30 μM,24 h) hydrochloride 在 Hela 细胞中促进外源性 TFEB (转录因子 EB) 的核易位,在 N2a 促进内源性 TFEB 的核易位,并伴随自噬通量和溶酶体生物发生的恢复。
Harmol (0-100 μM,24 和 48 h) hydrochloride 呈时间依赖性与剂量依赖性抑制 U251MG 细胞增殖,诱导细胞死亡。
Harmol (0-100 μM,0-48 h) hydrochloride 在 U251MG 细胞中抑制 survivin 的表达,促进 LC3-Ⅰ 和 LC3-Ⅱ 蛋白的表达,抑制 Akt/mTOR 通路,诱导细胞自噬和细胞凋亡。
Harmol (0-100 μM,0-24 h) 在 A549 和 H226 细胞中具有轻微细胞毒性,在 H596 中表现出很强的细胞毒性,抑制肿瘤增殖。
Harmol (60 μM,3-6 h) hydrochloride 提高了 caspase-3,caspase-6,caspase-8,caspase-9 活性,增加了 RAPA (caspase-3 内源性底物) 裂解,诱导 H596 细胞凋亡。
Harmol (1.3 μg/mL,1-3 h) hydrochloride 在 C2C12 细胞中激活了细胞自噬。
Harmol (1.3 μg/mL,45-60 min) hydrochloride 在 C2C12 细胞中是线粒体特异性自噬,且仅发生在无活性的 TMRM 阴性线粒体中。
Harmol (1.3 μg/mL,16 h) hydrochloride 在 C2C12 细胞中代表线粒体功能的标志物表达上调。
Harmol (1.3 μg/mL,0-20 h) hydrochloride 对 MAO-B 有特异性抑制作用。
Harmol hydrochloride 减少 GABA 能神经传递,但不能完全抑制 GABA 与 GABAAR 的结合,GABAAR 活性对 Harmol 介导的线粒体去极化至关重要,并依靠线粒体功能发挥作用。

Western Blot Analysis

Cell Line: Tet-on inducible PC12 cells; Hela, N2a; C2C12
Concentration: 3, 10, 30 μM; 30 μM; 1.3 μg/mL; 1.3 μg/mL
Incubation Time: 6, 12, 24 h; 24 h; 16 h; 24 h
Result: Reduced the phosphorylation (p-) and total α-syn levels in PC12 cells in a dose-dependent and time-dependent manner, showing pro-degradation activity between 6 and 24 hours.
Enhanced the LC3B-Ⅱ/LC3B-Ⅰ ratio in PC12 cells, promoted TFEB expression, and increased AMPK phosphorylation at the THr172 site. It facilitated the nuclear translocation of exogenous TFEB in HeLa cells and the translocation of endogenous TFEB to the nucleus in N2a cells. This also increased the expression of the lysosomal marker LAMP1 (lysosomal-associated membrane protein 1) precursor and the mature form of CTSD (cathepsin D).
Showed in C2C12, the protein expression of the mitochondrial transcription and replication factor TFAM and components of complex III (UQCRC2) and complex V (ATP5a) was significantly elevated, along with an increase in polyamine spermidine levels, while DYRK1A phosphorylation remained unchanged.

Immunofluorescence

Cell Line: Hela, PC12
Concentration: 30 μM
Incubation Time: 24 h
Result: Caused 60% of Flag-TFEB to undergo nuclear translocation and significantly increased the lysosomal content.

Cell Autophagy Assay

Cell Line: PC12; C2C12
Concentration: 3, 10, 30 μM; 1.3 μg/mL
Incubation Time: 24 h; 45, 60 min
Result: Promoted the autophagic degradation of p62 in PC12 induced cells.
Showed strong co-localization of lysosomes and mitochondria in C2C12 cells.
体内研究
(In Vivo)

Harmol (10-40 mg/kg,i.g.,一天两次,一个月) hydrochloride 在 α-syn 转基因小鼠模型中,可改善运动缺陷,包括运动和协调。下调黑质和前额皮质 α-syn 水平,增强自噬介导的蛋白质聚集体降解。
Harmol (100 mg/kg,灌胃,每日一次,三周) hydrochloride 在小鼠中有轻微的抗焦虑作用。
Harmol (100 mg/kg,口服,三个月) hydrochloride 改善肥胖小鼠胰岛素,葡萄糖稳态和代谢适应性,且对肾功能无影响。
Harmol (15 μg/kg,口服,0-50 天) hydrochloride 延长无脊椎动物的寿命。
Harmol (100 mg/kg,口服,两个月) hydrochloride 在老年小鼠延缓衰弱。

Animal Model: A53T α-syn mice
Dosage: 10, 20, 40 mg/kg; twice a day; one month
Administration: i.g.
Result: Made mice climb the rod faster, spent more time on the spinning rod, travelled farther in open areas, increased their step frequency and standing posture, reduced posture width, stride, step length, swing, and showed recovery of autonomous movement behavior.
Reduced the expression of α-syn and p62 in the brain’s substantia nigra and prefrontal cortex.
Increased the phosphorylation levels of AMPK Thr172 and TFEB in the substantia nigra, while decreasing the phosphorylation level of mTOR Ser2448.Increased the expression of LC3B-II/LC3B-I, LAMP1, pro-CTSD, and mature ctsd in the substantia nigra, while reducing the expression of p62 and p-ULK1(Ser757)/ULK1.
Animal Model: Male mice
Dosage: 100 mg/kg, single dose; 100 mg/kg, daily, 3 weeks
Administration: i.g.
Result: Showed no change in blood glucose levels, with no change in fasting-mediated ketone body increase, and low permeability of the blood-brain barrier. High levels in the liver and plasma, but low levels in the brain. The mitochondrial autophagy marker PINK1 was elevated, while the phosphorylation levels of AMPK target ACC1 or the autophagy marker LC3-II/LC3-I were unaffected.
Showed no change in the time mice spent in the aversive area (center) versus the non-aversive area (border), with no differences in elevated plus maze tests, and significantly less time spent in the dark/light box.
Increased phosphorylation of ACC2 in the liver and BAT, and levels of the mitochondrial autophagy marker PINK1 were also significantly elevated in the liver, BAT, and soleus.

化学信息

分子量 234.68
分子式 C12H11ClN2O
CAS No. 40580-83-4

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础